Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence.

doi:10.3748/wjg.v18.i33.4549

Article

Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence.

World journal of gastroenterology - 7 Sept 2012

Avoranta Suvi Tuulia, Korkeila Eija Annika, Syrjänen Kari Juhani, Pyrhönen Seppo Olavi, Sundström Jari Toivo Tapio

Abstract excerpt

AIM: To investigate the prognostic value of CD44 variant 6 (CD44v6), a membranous adhesion molecule, in rectal cancer. METHODS: Altogether, 210 rectal cancer samples from 214 patients treated with short-course radiotherapy (RT, n = 90), long-course (chemo) RT (n = 53) or surgery alone (n = 71) we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence.

Abstract excerpt

Topics

Related research